Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Boku, Inc (DI) Reg S Cat 3/144A (BOKU) by Steve Moore in ShareProphets
- Sell Vistry Group (VTY) by Steve Moore in ShareProphets
- Buy Avation (AVAP) by Canaccord Genuity
- Avoid Vianet Group (VNET) by Steve Moore in ShareProphets
- Buy Jet2 (JET2) by Canaccord Genuity
- Buy System1 Group (SYS1) by Canaccord Genuity
- Avoid Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Outperform Barratt Redrow (BTRW) by RBC Capital
- Buy The Gym Group (GYM) by Shore Capital
- Buy Next 15 Group (NFG) by Berenberg
- Buy Unite Group (UTG) by Berenberg
- Buy Victoria (VCP) by Berenberg
- Avoid EnSilica (ENSI) by Steve Moore in ShareProphets
- Hold BP (BP.) by Mark Hartley in The Motley Fool
- Buy Babcock International Group (BAB) by Robert Stephens (The Times) in The Times - Tempus
- Overweight Hochschild Mining (HOC) by Barclays
- Hold Keller Group (KLR) by Deutsche Bank
- Hold Hilton Food Group (HFG) by Kepler Cheuvreux
- Equal Weight BP (BP.) by Barclays
- Overweight Glencore (GLEN) by Barclays
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
NOTE: This is based on 392 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : 1,604.00p | Latest Ask : 1,607.00p |
| High Today : 1,658.00p | Low Today : 1,595.00p |
| This Years High : 2,028.00p | This Years Low : 1,191.00p |
| Volume : 1,294,156 | MKT Cap : £3551.47M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Deutsche Bank | Premium Only | 2026-06-22 14:15:00 22/06/2026 | -0.27% |
| Buy | Jefferies | Premium Only | 2026-05-05 04:25:00 05/05/2026 | 12.96% |
| Buy | Berenberg | Premium Only | 2026-04-28 10:31:00 28/04/2026 | 15.85% |
| Buy | Berenberg | Premium Only | 2026-03-04 15:31:00 04/03/2026 | 28.12% |
| Overweight | JP Morgan | Premium Only | 2026-03-03 04:55:00 03/03/2026 | 28.01% |
Hikma Pharmaceuticals (HIK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,604.00p | Latest Ask : 1,607.00p |
| High Today : 1,658.00p | Low Today : 1,595.00p |
| This Years High : 2,028.00p | This Years Low : 1,191.00p |
| Volume : 1,294,156 | MKT Cap : £3551.47M |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Deutsche Bank | Premium Only | 2026-06-22 14:15:00 22/06/2026 | -0.27% |
| Buy | Jefferies | Premium Only | 2026-05-05 04:25:00 05/05/2026 | 12.96% |
| Buy | Berenberg | Premium Only | 2026-04-28 10:31:00 28/04/2026 | 15.85% |
| Buy | Berenberg | Premium Only | 2026-03-04 15:31:00 04/03/2026 | 28.12% |
| Overweight | JP Morgan | Premium Only | 2026-03-03 04:55:00 03/03/2026 | 28.01% |